Dark

Check out our API

RSLS
ReShape Lifesciences, Inc. Common Stock
stock NASDAQ

Inactive

Aug 14, 2025

15.68USD+22.500%(+2.88)3,435,340

Pre-market

0.00USD-100.000%(-12.80)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 18, 2022

08:30AM EST Company to Present and Exhibit its Next-Generation Lap-Band Program Including its Supportive reshapecare Virtual Health Coaching Platform GlobeNewswire Inc

Jan 13, 2022

08:30AM EST ReShape Lifesciences Strengthens Leadership Team with Appointment GlobeNewswire Inc

Dec 20, 2021

08:35AM EST Life Sciences Companies Investor Presentations Now Available for On-Demand PR Newswire

Dec 15, 2021

10:30AM EST ReShape Lifesciences Granted European Patent Titled 'ULTRASONIC SYSTEMS AND METHODS FOR LOCATING AND /OR CHARACTERIZING INTRAGASTRIC DEVICES' Benzinga

Dec 9, 2021

12:20PM EST Life Sciences Virtual Investor Conference: Company Executives Present Live PR Newswire

08:35AM EST ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on PR Newswire

Nov 16, 2021

08:30AM EST ReShape Lifesciences Witnesses Great Success with GlobeNewswire Inc

Nov 11, 2021

08:30AM EST ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported its financial and operational results for the three and nine months ended September 30, 2021. GlobeNewswire Inc

03:55AM EST Earnings Scheduled For November 11, 2021 Benzinga

Nov 8, 2021

08:30AM EST ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it will report its third quarter 2021 financial and operational results on Thursday, November 11, 2021 at 8:30 a.m. ET. GlobeNewswire Inc

Nov 4, 2021

08:30AM EDT ReShape Lifesciences to Launch Line of ProCare GlobeNewswire Inc

Oct 19, 2021

08:50AM EDT ReShape Lifesciences To Present At Dawson James Small Cap Growth Conference Oct. 21, 2021 At 2:25 p.m. EDT Benzinga

08:30AM EDT ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas Stankovich, Chief Financial Officer of the Company, will present at the Annual Small Cap Growth Conference hosted by Dawson James Securities on October 21, 2021, at the Wyndham Grand Hotel in Jupiter, Florida. GlobeNewswire Inc

Oct 12, 2021

08:16AM EDT ReShape Lifesciences Highlights Launch Of Multi-Platform Consumer Ad Campaign To Market Its Next-Gen Lap Band Program Benzinga

08:00AM EDT The Companys first and largest mainstream mass-market advertising campaign GlobeNewswire Inc

Oct 8, 2021

02:36PM EDT Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher Benzinga

12:30PM EDT Mid-Day Market Update: Crude Oil Rises 2%; Allogene Therapeutics Shares Plunge Benzinga

11:52AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021 Benzinga

10:42AM EDT Shares of ReShape Lifesciences Inc. (RSLS) are jumping over 30% on Friday morning. Maxim Group initiated a coverage on ReShape Lifesciences with a Buy rating and a price target of $8.00. RTTNews

10:11AM EDT Mid-Morning Market Update: Markets Edge Higher; US Economy Adds 194,000 Jobs In September Benzinga

09:14AM EDT Maxim Group Initiates Coverage On Reshape Lifesciences with Buy Rating, Announces Price Target of $8 Benzinga

Sep 30, 2021

03:24PM EDT ReShape Lifesciences Receives Notice Of Allowance For Patent Titled 'INTRAGASTRIC DEVICE' Benzinga

Sep 23, 2021

08:00AM EDT ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company was highlighted in this weeks BioTuesdays feature article, titled ReShape Lifesciences forging weight loss and metabolic health solutions. The article stemmed from ReShape Lifesciences CEO Bart Bandys interview with BioTuesdays Editor in Chief Leonard Zehr. GlobeNewswire Inc

Sep 13, 2021

08:00AM EDT ReShape Lifesciences to Host Exhibit at GlobeNewswire Inc

Sep 9, 2021

08:30AM EDT ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced that its leadership will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on Monday, September 20, 2021, at 2:05 p.m. ET. GlobeNewswire Inc

Aug 31, 2021

04:35PM EDT Reshape Lifesciences CFO Stankovich Thomas Buys 15K Shares At Average Price Of $3.43/Share Benzinga

08:00AM EDT ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the appointment of Al Diaz as Vice President of Operations and Research and Development. Mr. Diaz will be responsible for overseeing the companys manufacturing operations and research and development efforts. GlobeNewswire Inc

Aug 19, 2021

06:01AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.30 A.M. EDT). RTTNews

Aug 5, 2021

08:12AM EDT ReShape Lifesciences Sees Q2 Sales $3.5M, Gross Profit $2.1M Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Jul 13, 2021

08:35AM EDT ReShape Lifesciences Launches Online Consumer Marketplace Benzinga

Jul 9, 2021

08:09AM EDT Benzinga Pro's Top 5 Stocks To Watch For Friday, Jul. 9, 2021: GS, HGEN, TBLT, ANY, RSLS Benzinga

Jul 7, 2021

08:36AM EDT ReShape Lifescience Highlights Completion Of Lap-Band Manufacturing Transition To Massachusetts-Based Manufacturer Benzinga

Jul 2, 2021

11:32AM EDT ReShape Lifesciences Granted European Patent Titled, 'ULTRASONIC SYSTEMS AND METHODS FOR LOCATING AND/OR CHARACTERIZING INTRAGASTRIC DEVICES' Benzinga

Jul 1, 2021

08:35AM EDT ReShape Lifesciences Says Utilization Of Its Lap-Band Increased During COVID-19 Pandemic Benzinga

Jun 28, 2021

11:44AM EDT Shares of ReShape Lifesciences Inc. (RSLS) are currently gaining over 20% despite no stock related news to drive the shares. RTTNews

05:46AM EDT ReShape Lifesciences Shares Up 23% Premarket After Armistice Capital Reported an ~50% Stake in a Filing on Friday Benzinga

Jan 22, 2021

04:46PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Obalon Therapeutics, Inc. (NASDAQ: OBLN) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by ReShape Lifesciences Inc. (Other OTC: RSLS). GlobeNewswire Inc

Jan 21, 2021

02:57PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc. PR Newswire

Sep 15, 2020

08:02AM EDT First Twenty-five Healthcare Professionals Enrolled in ReShapeCare(tm), a PR Newswire

Sep 10, 2020

09:37AM EDT ReShape Lifesciences Announces Positive Preclinical Results For Diabetes Bloc-Stim Neuromodulation Device RTTNews

Aug 13, 2020

08:18AM EDT The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga

Share